The Effect of the Microbiome on Immune Checkpoint Inhibitor Response in Melanoma Patients

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

February 10, 2020

Primary Completion Date

May 5, 2022

Study Completion Date

May 5, 2022

Conditions

Clinical Stage IV Cutaneous Melanoma AJCC v8Pathologic Stage IV Cutaneous Melanoma AJCC v8

Interventions

PROCEDURE

Biospecimen Collection

Undergo collection of blood and stool

PROCEDURE

Computed Tomography

Undergo CT

OTHER

Laboratory Biomarker Analysis

Correlative studies

OTHER

Questionnaire Administration

Complete questionnaire

Trial Locations (1)

Ohio State University Comprehensive Cancer Center, Columbus

All Listed Sponsors

lead

Ohio State University Comprehensive Cancer Center

OTHER

NCT05102773 - The Effect of the Microbiome on Immune Checkpoint Inhibitor Response in Melanoma Patients | Biotech Hunter | Biotech Hunter